第一单位：
Dept. Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
作者：
Laura S,Mertens [1]
;
Francesco,Claps [1]
;
Roman,Mayr [2]
;
Peter J,Bostrom [3]
;
Shahrokh F,Shariat [4]
;
Ellen C,Zwarthoff [5]
;
Joost L,Boormans [6]
;
Cheno,Abas [5]
;
Geert J L H,van Leenders [5]
;
Stefanie,Götz [2]
;
Katrin,Hippe [7]
;
Simone,Bertz [8]
;
Yann,Neuzillet [9]
;
Joyce,Sanders [10]
;
Annegien,Broeks [10]
;
Dennis,Peters [10]
;
Michiel S,van der Heijden [11]
;
Michael A S,Jewett [12]
;
Robert,Stöhr [8]
;
Alexandre R,Zlotta [12]
;
Markus,Eckstein [8]
;
Yanish,Soorojebally [13]
;
Deric K E,van der Schoot [14]
;
Bernd,Wullich [15]
;
Maximilian,Burger [2]
;
Wolfgang,Otto [2]
;
François,Radvanyi [13]
;
Nanour,Sirab [13]
;
Damien,Pouessel [16]
;
Theo H,van der Kwast [17]
;
Arndt,Hartmann [8]
;
Yair,Lotan [4]
;
Yves,Allory [18]
;
Tahlita C M,Zuiverloon [19]
;
Bas W G,van Rhijn [20]
作者单位：
Dept. Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
[1]
Dept. Urology, Caritas St Josef Medical Center, University of Regensburg, Regensburg, Germany.
[2]
Dept. Surgery (Urology) and Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada; Dept. Urology, Turku University Hospital and University of Turku, Turku, Finland.
[3]
Dept. Urology, University of Texas Southwestern Medical center, Dallas, TX.
[4]
Dept. of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
[5]
Dept. Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
[6]
Dept. Pathology, University Medical Center - Regensburg, Regensburg, Germany.
[7]
Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen/Nurnberg, Erlangen, Germany.
[8]
Dept. Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Institut Curie, CNRS, UMR144, Molecular Oncology team, PSL Research University, Paris, France; Core Facility Molecular Pathology & Biobank, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
[9]
Core Facility Molecular Pathology & Biobank, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
[10]
Dept. Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
[11]
Dept. Surgery (Urology) and Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.
[12]
Institut Curie, CNRS, UMR144, Molecular Oncology team, PSL Research University, Paris, France.
[13]
Dept. Urology, Amphia Hospital, Breda, The Netherlands.
[14]
Dept. Urology & Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen/Nurnberg, Erlangen, Germany.
[15]
Dept. Medical Oncology, Claudius Regaud Institute, Toulouse University Cancer Center (IUCT) Oncopole, Toulouse, France.
[16]
Dept. Pathology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.
[17]
Institut Curie, CNRS, UMR144, Molecular Oncology team, PSL Research University, Paris, France; Dept. Pathology, Institut Curie, Paris, France.
[18]
Dept. of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Dept. Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands. Electronic address: t.zuiverloon@erasmusmc.nl.
[19]
Dept. Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Dept. Urology, Caritas St Josef Medical Center, University of Regensburg, Regensburg, Germany; Dept. Surgery (Urology) and Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada. Electronic address: b.v.rhijn@nki.nl.
[20]
DOI
10.1016/j.urolonc.2021.10.010
PMID
34906411
发布时间
2022-05-31
换一批
